Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy for low-grade gliomas: emerging consensus on its benefits.

× No keyword cloud information.

8 in total

1. Upfront chemotherapy and subsequent resection for molecularly defined gliomas.

Authors: Hikaru Sasaki; Yuichi Hirose; Takahito Yazaki; Yohei Kitamura; Makoto Katayama; Tokuhiro Kimura; Hirokazu Fujiwara; Masahiro Toda; Takayuki Ohira; Kazunari Yoshida
Journal: J Neurooncol Date: 2015-05-26 Impact factor: 4.130

2. Current Management of Adult Diffuse Infiltrative Low Grade Gliomas.

Authors: Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal: Curr Neurol Neurosci Rep Date: 2016-02 Impact factor: 5.081

3. Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.

Authors: David A Reardon; Annick Desjardins; James J Vredenburgh; James E Herndon; April Coan; Sridharan Gururangan; Katherine B Peters; Roger McLendon; Sith Sathornsumetee; Jeremy N Rich; Eric S Lipp; Dorothea Janney; Henry S Friedman
Journal: Cancer Date: 2012-02-27 Impact factor: 6.860

4. Efficacy and safety of bevacizumab for the treatment of glioblastoma.

Authors: Zhiyun Yu; Gang Zhao; Zhonghua Zhang; Yunqian Li; Yong Chen; Nan Wang; Zhongying Zhao; Guifang Xie
Journal: Exp Ther Med Date: 2015-12-16 Impact factor: 2.447

5. Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.

Authors: Oliver Schnell; Bjarne Krebs; Janette Carlsen; Isabelle Miederer; Claudia Goetz; Roland H Goldbrunner; Hans-Jürgen Wester; Roland Haubner; Gabriele Pöpperl; Markus Holtmannspötter; Hans A Kretzschmar; Horst Kessler; Jörg-Christian Tonn; Markus Schwaiger; Ambros J Beer
Journal: Neuro Oncol Date: 2009-12 Impact factor: 12.300

Review 6. Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.

Authors: Kathryn Beal; Lauren E Abrey; Philip H Gutin
Journal: Radiat Oncol Date: 2011-01-07 Impact factor: 3.481

7. PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival.

Authors: Georgios Batsios; Pavithra Viswanath; Elavarasan Subramani; Chloe Najac; Anne Marie Gillespie; Romelyn Delos Santos; Abigail R Molloy; Russell O Pieper; Sabrina M Ronen
Journal: Sci Rep Date: 2019-07-19 Impact factor: 4.379

8. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.

Authors: Jing Zeng; Xin-Ke Zhang; Hua-Dong Chen; Zhi-Hai Zhong; Qiu-Liang Wu; Su-Xia Lin
Journal: Oncotarget Date: 2016-02-23

8 in total